Seeking Alpha

Medhanie

 
View as an RSS Feed
View Medhanie's Comments BY TICKER:
Latest  |  Highest rated
  • Amarin's Descent To $5 [View article]
    Volatility is inevitable... If you're a day trader, congrats.
    Mar 6 03:26 PM | Likes Like |Link to Comment
  • Groupon: Growth Vs. Profitability [View article]
    I actually have used Groupon and I find that you get what you pay for. To me, it's equivalent to Priceline's Name Your Own Price model; you can get a flight super cheap but there is a heavy price to pay in terms of connections, time day you flight leaves, and the fact that it is non-refundable or transferable. I think most Groupon customers go into it aware of that.
    Mar 5 04:34 PM | 1 Like Like |Link to Comment
  • EnteroMedics May Get Approval, But Will It Get Sales? [View article]
    Nice article.... I agree with you. However, I would chances at approval at 50/50. Reason being that it was about the same efficacy of Belviq with a lot less side effects. Also, remember the FAD was essentially mandated by the congress to bring treatment option for obesity onto the market. BLOC seems to fill that need for options without the heavy effects of Qsymia, Contrave, or Belviq or any of the other surgical options. I also don't know if the stock is worth $5 with approval. Like you said, the market potential is very limited, but I do see it trading as high $3 and may be even peak around $3.50.
    Feb 12 09:10 AM | Likes Like |Link to Comment
  • Amarin: Short Now, Long Later [View article]
    Did I elicit some insecurity in you??
    Dec 29 01:13 PM | Likes Like |Link to Comment
  • In Defense Of Groupon's Andrew Mason [View article]
    Why do you think Groupon is a massive fraud?
    Dec 29 03:11 AM | Likes Like |Link to Comment
  • Complete Genomics: Say No To Sale [View article]
    Unfortunafely, we don't have many options. Once BGI owns a majority of the oustanding shares, it can simply force the rest of the shareholders to sell at the offer price. In effect, it's a done deal.
    Sep 27 01:52 PM | Likes Like |Link to Comment
  • Complete Genomics: Say No To The Sale - Part 2 [View article]
    It sucks... sorry.
    Sep 26 03:10 PM | Likes Like |Link to Comment
  • Complete Genomics: Say No To Sale [View article]
    Management own about 17% of the shares. They have committed those shares to the tender offer. Beyond that there were no additional announcement of compensation althought the the existing management is expected to stay on, which presumably includes some new compensation structure that may be more lucrative than the old structure.
    Sep 25 02:48 PM | Likes Like |Link to Comment
  • Complete Genomics May Be Worth The Gamble [View article]
    Do yourself a favor and stop talking. You're an idiot.
    Sep 25 02:39 PM | Likes Like |Link to Comment
  • Despite Challenges, Obagi Is Still A Buy [View article]
    Don't know who that is.
    Aug 29 07:10 PM | Likes Like |Link to Comment
  • Despite Challenges, Obagi Is Still A Buy [View article]
    Their products have a good reputation. There were very few customer or doctor complaints, even outside of Amazon. I agree they can't live forever on what they have done. But under the right leadership, they can def build on what they have and have done. This is why I say I like Obagi for now.
    Aug 29 07:09 PM | 1 Like Like |Link to Comment
  • Despite Challenges, Obagi Is Still A Buy [View article]
    Thank You!
    Aug 29 07:05 PM | Likes Like |Link to Comment
  • Complete Genomics May Be Worth The Gamble [View article]
    Lying is a big accusation. GNOM has operated with intergrity. Its CEO, Cliff Reid, is really an admirable guy. He has an outstanding track record work and character. So before you impune someone, make sure you have evidence in hand.
    Jul 20 10:58 PM | Likes Like |Link to Comment
  • Complete Genomics May Be Worth The Gamble [View article]
    It's important but not crucial in either direction.
    Jul 20 10:55 PM | Likes Like |Link to Comment
  • Complete Genomics May Be Worth The Gamble [View article]
    The point is that GNOM is at real rist of not being able to raise capital and losing the lawsuit.
    Jul 20 10:53 PM | Likes Like |Link to Comment
COMMENTS STATS
99 Comments
40 Likes